← Leaderboards
Yongmei Xu
Glycan Therapeutics Corporation
$1,933,798
Attributed
$1,933,798
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $855.9K · FY2018–20$1M$750K$500K$250K$0
'18
'19
'20
Funding mix
By agency
NIH$1,933,798 · 1
By mechanism
R42$1,933,798 · 1
Top collaborators
No co-investigators on record.
Most similar at Glycan Therapeutics Corporation
Same institution · by research overlap
- Vijayakanth Pagadala$12,153,122
- Guowei Su$5,499,306
- Zhangjie Wang$4,365,125
- Quin Shi$299,447
- Katelyn Arnold$1,234,308
Others in their field
Other Emerging Leaders on “Mammalian Cell”
- Tomasz Nowakowski · University Of California, San Francisco$9,024,950
- Francois St-Pierre · Baylor College Of Medicine$8,062,021
- Bing Yao · Emory University$6,439,866
- Junyue Cao · Rockefeller University$5,813,031
- Terry Roemer · Prokaryotics, Inc.$5,773,697
- Xin Duan · University Of California, San Francisco$5,692,313
Research focus
Mammalian CellOligosaccharidesInnovationLibrariesMemberNorth CarolinaHeparitin SulfateBaseLaboratoriesBiological ProcessBiological ResearchGlycosaminoglycansCell SurfaceBiochemistryChondroitin SulfatesBiotechnologyCost EffectiveDesignCarbohydratesInstitutesEnzymesExtracellular MatrixFamilyPolysaccharides
Grant awards (5)
Enzymatic synthesis of heparin sulfate and chondroitin sulfate$736,388
R42 · FY2020 · GM · contact PI
LC-MS System to Determine the Molecular Mass of Synthesized Heparan and Chondroitin Sulfate Oligosaccharides$119,500
R42 · FY2020 · GM · contact PI
Enzymatic synthesis of heparin sulfate and chondroitin sulfate$743,671
R42 · FY2019 · GM · contact PI
Enzymatic synthesis of heparin sulfate and chondroitin sulfate$224,650
R42 · FY2018 · GM · contact PI
Reactor for Insect Cell Culture$109,589
R42 · FY2018 · GM · contact PI